Navigation Links
Nature as a source of new medicines subject of ICNPR in NYC
Date:7/20/2012

The urgent need to evaluate nature's repository of chemicals in plants, microbes, and marine organisms for their potential value in health care will be a major theme of a five-day scientific conference in New York that is expected to draw some 1,200 natural products researchers from around the world.

Organized and co-hosted by The New York Botanical Garden, the City University of New York, and other New York-area research institutions, the International Congress on Natural Products Research (ICNPR) will be held from July 28 to August 1 at the Grand Hyatt Hotel in New York City. The theme of the conference is "Global Change, Natural Products and Human Health."

Several scientists from the Botanical Garden will take part in ICNPR events at the Grand Hyatt, and on July 26, the Garden's Midtown Education Center, located on West 44th Street, will host a special presentation about the development of Taxol, the widely used chemotherapy drug first isolated from the bark of the Pacific yew tree.

Focusing on the study of medicines derived from natural sources, the ICNPR will feature sessions devoted to the traditional areas of natural products researchmarine, microbial, and plant sources of medicinal chemicalsas well as the latest developments in analytical technologies, genomics, and many other areas of natural products work. Organizers expect it to be the largest U.S. gathering to date of natural products researchers.

From simple aspirin to sophisticated cancer-fighting drugs such as Taxol, the natural world has served as an important source of medically active compounds. That resource is under increasing strain from such global environmental problems as climate change and habitat destruction, yet only a fraction of the many thousands of plant, microbial, and marine species have been studied to determine if the chemicals they produce could be the basis of new pharmaceuticals to treat or prevent human illness.

This critical si
'/>"/>

Contact: Stevenson Swanson
pubrel@nybg.org
718-817-8616
The New York Botanical Garden
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Force of nature: Defining the mechanical mechanisms in living cells
2. First direct evidence that elemental fluorine occurs in nature
3. NUS launches new book on Singapores rainforests and new free digital nature archive
4. Nature: Molecule changes magnetism and conductance
5. Risks and rewards of quantifying natures ecosystem services
6. Voicemail discovered in nature
7. Nature or nurture? It may depend on where you live
8. Nature: Microscope looks into cells of living fish
9. Biosignatures distinguish between tuberculosis and sarcoidosis
10. Can natures beauty lift citizens from poverty?
11. Natures billion-year-old battery key to storing energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... Why Tibetan antelope can live at elevations of ... research published in Nature Communications , investigators ... evidence that some genetic factors may be associated ... The data in this work will also provide ... biology of other ruminant species. , The Tibetan ...
Breaking Biology News(10 mins):Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4First Atlanta Science Festival set for 2014 2The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... undergo polar body diagnosis go on to have a child. ... by researchers in reproductive medicine at Lbeck in an article ... in which they present three successful cases and one failure ... are by-products of normal cell division (meiosis) of an oocytea ...
... of the Americasmight be forgiven for thinking that all ... among dense forest understory are butterflies. In fact, many ... as butterflies, converging on the daytime niche typically dominated ... of the taxonomic relationships among one such group of ...
... usefulness in counting copies of duplicated genome sequences and in ... to be published Aug. 30 in Nature Genetics . ... from one person to the next. The researchers named ... Tool. The study is titled, "Personalized Copy Number and Segmental ...
Cached Biology News:New developments in reproductive medicine 2Moths cloaked in color 2Moths cloaked in color 3Moths cloaked in color 4Counting duplicated genome segments now possible 2Counting duplicated genome segments now possible 3
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ultra-low ... USA, won the Outstanding New Product Award presented on ... and Environmental Repositories (ISBER) at their annual meeting in ... recognizes the company’s development and introduction of the world’s ... was presented to Global Cooling’s CEO Neill Lane by ...
(Date:5/16/2013)... May 16, 2013 A new ... models, from Cole-Parmer is designed to meet the ... includes: , The new Cole-Parmer® MS-3400 Centrifuges ... in the lab. They ensure a powerful and ... specimen separation. Their standard four-place swinging buckets hold ...
(Date:5/16/2013)... 2013  The registration deadline has been extended until ... 2013 National Conference, the premier conference for bioscience financial ... the Hilton San Diego Bayfront. "We ... and want to make sure as many people as ... Brandi Roberts , Chief Financial Officer of Mast ...
(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The new ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... Ltd. (NYSE Amex:, SVA ), a leading developer and provider of ... and twelve month,periods ended December 31, 2008. , , ... 2008 sales increasing 39% year-over-year to $46.5, ... in 2008, up from 5.12 million in, ...
... Biotech Ltd. (NYSE Amex:, SVA ), a leading developer and provider ... three and twelve month,periods ended December 31, 2008. , , ... year 2008 sales increasing 39% year-over-year to $46.5, ... Healive(R) in 2008, up from 5.12 million in, ...
... CPHD ) today announced that it will report ... 2009, on Thursday, April 23, 2009, after the close of ... p.m. Pacific Time on Thursday, April 23, 2009, to discuss ... Cepheid,s website at www.cepheid.com/investors at least ...
Cached Biology Technology:Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results 13Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast 2